Heterogeneous pseudobulk simulation enables realistic benchmarking of cell-type deconvolution methods.


Journal

Genome biology
ISSN: 1474-760X
Titre abrégé: Genome Biol
Pays: England
ID NLM: 100960660

Informations de publication

Date de publication:
01 07 2024
Historique:
received: 20 01 2023
accepted: 29 05 2024
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 3 7 2024
Statut: epublish

Résumé

Computational cell type deconvolution enables the estimation of cell type abundance from bulk tissues and is important for understanding tissue microenviroment, especially in tumor tissues. With rapid development of deconvolution methods, many benchmarking studies have been published aiming for a comprehensive evaluation for these methods. Benchmarking studies rely on cell-type resolved single-cell RNA-seq data to create simulated pseudobulk datasets by adding individual cells-types in controlled proportions. In our work, we show that the standard application of this approach, which uses randomly selected single cells, regardless of the intrinsic difference between them, generates synthetic bulk expression values that lack appropriate biological variance. We demonstrate why and how the current bulk simulation pipeline with random cells is unrealistic and propose a heterogeneous simulation strategy as a solution. The heterogeneously simulated bulk samples match up with the variance observed in real bulk datasets and therefore provide concrete benefits for benchmarking in several ways. We demonstrate that conceptual classes of deconvolution methods differ dramatically in their robustness to heterogeneity with reference-free methods performing particularly poorly. For regression-based methods, the heterogeneous simulation provides an explicit framework to disentangle the contributions of reference construction and regression methods to performance. Finally, we perform an extensive benchmark of diverse methods across eight different datasets and find BayesPrism and a hybrid MuSiC/CIBERSORTx approach to be the top performers. Our heterogeneous bulk simulation method and the entire benchmarking framework is implemented in a user friendly package https://github.com/humengying0907/deconvBenchmarking and https://doi.org/10.5281/zenodo.8206516 , enabling further developments in deconvolution methods.

Sections du résumé

BACKGROUND
Computational cell type deconvolution enables the estimation of cell type abundance from bulk tissues and is important for understanding tissue microenviroment, especially in tumor tissues. With rapid development of deconvolution methods, many benchmarking studies have been published aiming for a comprehensive evaluation for these methods. Benchmarking studies rely on cell-type resolved single-cell RNA-seq data to create simulated pseudobulk datasets by adding individual cells-types in controlled proportions.
RESULTS
In our work, we show that the standard application of this approach, which uses randomly selected single cells, regardless of the intrinsic difference between them, generates synthetic bulk expression values that lack appropriate biological variance. We demonstrate why and how the current bulk simulation pipeline with random cells is unrealistic and propose a heterogeneous simulation strategy as a solution. The heterogeneously simulated bulk samples match up with the variance observed in real bulk datasets and therefore provide concrete benefits for benchmarking in several ways. We demonstrate that conceptual classes of deconvolution methods differ dramatically in their robustness to heterogeneity with reference-free methods performing particularly poorly. For regression-based methods, the heterogeneous simulation provides an explicit framework to disentangle the contributions of reference construction and regression methods to performance. Finally, we perform an extensive benchmark of diverse methods across eight different datasets and find BayesPrism and a hybrid MuSiC/CIBERSORTx approach to be the top performers.
CONCLUSIONS
Our heterogeneous bulk simulation method and the entire benchmarking framework is implemented in a user friendly package https://github.com/humengying0907/deconvBenchmarking and https://doi.org/10.5281/zenodo.8206516 , enabling further developments in deconvolution methods.

Identifiants

pubmed: 38956606
doi: 10.1186/s13059-024-03292-w
pii: 10.1186/s13059-024-03292-w
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

169

Subventions

Organisme : NSF
ID : NSF 2238125
Organisme : NIH R01
ID : NIH R01 HG 009299-6A1
Organisme : NIH R01
ID : NIH R01 EY 030546-01A1
Organisme : DARPA
ID : DARPA W911NF-23-2-0023
Organisme : NHGRI NIH HHS
ID : R01 HG009299
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY030546
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Avila Cobos F, Vandesompele J, Mestdagh P, De Preter K. Computational deconvolution of transcriptomics data from mixed cell populations. Bioinformatics (Oxford, England). 2018;34(11):1969–79. https://doi.org/10.1093/bioinformatics/bty019 .
doi: 10.1093/bioinformatics/bty019 pubmed: 29351586
Sutton GJ, Poppe D, Simmons RK, Walsh K, Nawaz U, Lister R, et al. Comprehensive evaluation of deconvolution methods for human brain gene expression. Nat Commun. 2022;13(1):1358. https://doi.org/10.1038/s41467-022-28655-4 .
doi: 10.1038/s41467-022-28655-4 pubmed: 35292647 pmcid: 8924248
Zhang H, Lu X, Lu B, Gullo G, Chen L. Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future. Futur Oncol. 2024. https://doi.org/10.2217/fon-2023-0658 .
Bruno TC. B cells to the forefront of immunotherapy. Nature. 2020;577(7791):474–6. https://doi.org/10.1038/d41586-019-03943-0 .
doi: 10.1038/d41586-019-03943-0 pubmed: 31965091 pmcid: 7523515
Barrett RL, Puré E. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy. eLife. 2020;9:e57243. https://doi.org/10.7554/eLife.57243 .
doi: 10.7554/eLife.57243 pubmed: 33370234 pmcid: 7769568
Raskov H, Orhan A, Christensen JP, Gögenur I. Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124(2):359–67. https://doi.org/10.1038/s41416-020-01048-4 .
doi: 10.1038/s41416-020-01048-4 pubmed: 32929195
González-Navajas JM, Fan DD, Yang S, Yang FM, Lozano-Ruiz B, Shen L, et al. The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies. Front Immunol. 2021;12:625783. https://doi.org/10.3389/fimmu.2021.625783 .
doi: 10.3389/fimmu.2021.625783 pubmed: 33717139 pmcid: 7952426
Darvin P, Toor SM, Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med. 2018;50(12):1–11. https://doi.org/10.1038/s12276-018-0191-1 .
doi: 10.1038/s12276-018-0191-1 pubmed: 30546008
Avila Cobos F, Alquicira-Hernandez J, Powell JE, Mestdagh P, De Preter K. Benchmarking of cell type deconvolution pipelines for transcriptomics data. Nat Commun. 2020;11(1):5650. https://doi.org/10.1038/s41467-020-19015-1 .
doi: 10.1038/s41467-020-19015-1 pubmed: 33159064 pmcid: 7648640
Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220. https://doi.org/10.1186/s13059-017-1349-1 .
doi: 10.1186/s13059-017-1349-1 pubmed: 29141660 pmcid: 5688663
Zhong Y, Wan YW, Pang K, Chow LML, Liu Z. Digital sorting of complex tissues for cell type-specific gene expression profiles. BMC Bioinformatics. 2013;14:89. https://doi.org/10.1186/1471-2105-14-89 .
doi: 10.1186/1471-2105-14-89 pubmed: 23497278 pmcid: 3626856
Chen L, Wu CT, Wang N, Herrington DM, Clarke R, Wang Y. debCAM: a bioconductor R package for fully unsupervised deconvolution of complex tissues. Bioinformatics. 2020;36(12):3927–9. https://doi.org/10.1093/bioinformatics/btaa205 .
doi: 10.1093/bioinformatics/btaa205 pubmed: 32219387 pmcid: 7320609
Wu CT, Chen L, Herrington DM, Shen M, Yu G, Clarke R, et al. Determining molecular archetype composition and expression from bulk tissues with unsupervised deconvolution. bioRxiv. 2021. https://doi.org/10.1101/2021.07.12.452047 .
Zaitsev K, Bambouskova M, Swain A, Artyomov MN. Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures. Nat Commun. 2019;10(1):2209. https://doi.org/10.1038/s41467-019-09990-5 .
doi: 10.1038/s41467-019-09990-5 pubmed: 31101809 pmcid: 6525259
Chu T, Wang Z, Pe’er D, Danko CG. Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology. Nat Cancer. 2022;3(4):505–17. https://doi.org/10.1038/s43018-022-00356-3 .
doi: 10.1038/s43018-022-00356-3 pubmed: 35469013 pmcid: 9046084
Jin H, Liu Z. A benchmark for RNA-seq deconvolution analysis under dynamic testing environments. Genome Biol. 2021;22(1):102. https://doi.org/10.1186/s13059-021-02290-6 .
doi: 10.1186/s13059-021-02290-6 pubmed: 33845875 pmcid: 8042713
Sturm G, Finotello F, Petitprez F, Zhang JD, Baumbach J, Fridman WH, et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics (Oxford, England). 2019;35(14):i436–45. https://doi.org/10.1093/bioinformatics/btz363 .
doi: 10.1093/bioinformatics/btz363 pubmed: 31510660 pmcid: 6612828
Chen Y, Wang Y, Chen Y, Cheng Y, Wei Y, Li Y, et al. Deep autoencoder for interpretable tissue-adaptive deconvolution and cell-type-specific gene analysis. Nat Commun. 2022;13(1):6735. https://doi.org/10.1038/s41467-022-34550-9 .
doi: 10.1038/s41467-022-34550-9 pubmed: 36347853 pmcid: 9641692
Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11(1):34. https://doi.org/10.1186/s13073-019-0638-6 .
doi: 10.1186/s13073-019-0638-6 pubmed: 31126321 pmcid: 6534875
Andrade Barbosa B, van Asten SD, Oh JW, Farina-Sarasqueta A, Verheij J, Dijk F, et al. Bayesian log-normal deconvolution for enhanced in silico microdissection of bulk gene expression data. Nat Commun. 2021;12(1):6106. https://doi.org/10.1038/s41467-021-26328-2 .
doi: 10.1038/s41467-021-26328-2 pubmed: 34671028 pmcid: 8528834
Gavish A, Tyler M, Greenwald AC, Hoefflin R, Simkin D, Tschernichovsky R, et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature. 2023;618(7965):598–606. https://doi.org/10.1038/s41586-023-06130-4 .
doi: 10.1038/s41586-023-06130-4 pubmed: 37258682
Torroja C, Sanchez-Cabo F. Digitaldlsorter: Deep-Learning on scRNA-Seq to Deconvolute Gene Expression Data. Front Genet. 2019;10:978. https://doi.org/10.3389/fgene.2019.00978 .
doi: 10.3389/fgene.2019.00978 pubmed: 31708961 pmcid: 6824295
Dong M, Thennavan A, Urrutia E, Li Y, Perou CM, Zou F, et al. SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing references. Brief Bioinforma. 2021;22(1):416–27. https://doi.org/10.1093/bib/bbz166 .
doi: 10.1093/bib/bbz166
Menden K, Marouf M, Oller S, Dalmia A, Magruder DS, Kloiber K, et al. Deep learning-based cell composition analysis from tissue expression profiles. Sci Adv. 2020;6(30):eaba2619. https://doi.org/10.1126/sciadv.aba2619 .
doi: 10.1126/sciadv.aba2619 pubmed: 32832661 pmcid: 7439569
Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171(7):1611-1624.e24. https://doi.org/10.1016/j.cell.2017.10.044 .
doi: 10.1016/j.cell.2017.10.044 pubmed: 29198524 pmcid: 5878932
Boyeau P, Hong J, Gayoso A, Jordan MI, Azizi E, Yosef N. Deep generative modeling for quantifying sample-level heterogeneity in single-cell omics. bioRxiv. 2022. https://doi.org/10.1101/2022.10.04.510898 .
Goldman MJ, Craft B, Hastie M, Repečka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–8. https://doi.org/10.1038/s41587-020-0546-8 .
doi: 10.1038/s41587-020-0546-8 pubmed: 32444850 pmcid: 7386072
Tirosh I, Puram S, Parikh A. Single cell RNA-seq analysis of head and neck cancer. Gene Expr Omnibus. 2017. https://identifiers.org/geo:GSE103322 . Accessed Apr 2022.
Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352(6282):189–96. https://doi.org/10.1126/science.aad0501 .
doi: 10.1126/science.aad0501 pubmed: 27124452 pmcid: 4944528
Tirosh I, Izar B. Single cell RNA-seq analysis of melanoma. Gene Expr Omnibus. 2016. https://identifiers.org/geo:GSE72056 . Accessed Apr 2022.
Riemondy KA, Venkataraman S, Willard N, Nellan A, Sanford B, Griesinger AM, et al. Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma. Neuro-Oncol. 2022;24(2):273–86. https://doi.org/10.1093/neuonc/noab135 .
doi: 10.1093/neuonc/noab135 pubmed: 34077540
Riemondy K, Donson A. Single-cell RNAseq of childhood medulloblastoma. Gene Expr Omnibus. 2021. https://identifiers.org/geo:GSE155446 . Accessed May 2022.
Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell. 2018;175(4):984-997.e24. https://doi.org/10.1016/j.cell.2018.09.006 .
doi: 10.1016/j.cell.2018.09.006 pubmed: 30388455 pmcid: 6410377
Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, et al.. Single-cell RNA-seq of melanoma ecosystems reveals sources of T cells exclusion linked to immunotherapy clinical outcomes. Gene Expr Omnibus. 2018. https://identifiers.org/geo:GSE115978 . Accessed May 2022.
Lee HO, Hong Y, Etlioglu HE, Cho YB, Pomella V, Van den Bosch B, et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat Genet. 2020;52(6):594–603. https://doi.org/10.1038/s41588-020-0636-z .
doi: 10.1038/s41588-020-0636-z pubmed: 32451460
Curated Cancer Cell Atlas Research Group. The Curated Cancer Cell Atlas: Colorectal Cancer Data from Lee et al., 2020. Curated Cancer Cell Atlas. 2023. https://www.weizmann.ac.il/sites/3CA/colorectal . Accessed Sept 2023.
Qian J, Olbrecht S, Boeckx B, Vos H, Laoui D, Etlioglu E, et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res. 2020;30(9):745–62. https://doi.org/10.1038/s41422-020-0355-0 .
doi: 10.1038/s41422-020-0355-0 pubmed: 32561858 pmcid: 7608385
Curated Cancer Cell Atlas Research Group. The Curated Cancer Cell Atlas: Breaset Cancer Data from Qian et al., 2020. Curated Cancer Cell Atlas. 2023. https://www.weizmann.ac.il/sites/3CA/breast . Accessed Sept 2023.
Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285. https://doi.org/10.1038/s41467-020-16164-1 .
doi: 10.1038/s41467-020-16164-1 pubmed: 32385277 pmcid: 7210975
Curated Cancer Cell Atlas Research Group. The Curated Cancer Cell Atlas: Lung Cancer Data from Kim et al., 2020. Curated Cancer Cell Atlas. 2023. https://www.weizmann.ac.il/sites/3CA/lung . Accessed Sep 2023.
Izar B, Tirosh I, Stover EH, Wakiro I, Cuoco MS, Alter I, et al. A single-cell landscape of high-grade serous ovarian cancer. Nat Med. 2020;26(8):1271–9. https://doi.org/10.1038/s41591-020-0926-0 .
doi: 10.1038/s41591-020-0926-0 pubmed: 32572264 pmcid: 7723336
Curated Cancer Cell Atlas Research Group. The Curated Cancer Cell Atlas: Ovarian Cancer Data from Izar et al., 2020. Curated Cancer Cell Atlas. 2023. https://www.weizmann.ac.il/sites/3CA/ovarian . Accessed Sep 2023.
Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417–25. https://doi.org/10.1016/j.cels.2015.12.004 .
doi: 10.1016/j.cels.2015.12.004 pubmed: 26771021 pmcid: 4707969
Jiang R, Sun T, Song D, Li JJ. Statistics or biology: the zero-inflation controversy about scRNA-seq data. Genome Biol. 2022;23(1):31. https://doi.org/10.1186/s13059-022-02601-5 .
doi: 10.1186/s13059-022-02601-5 pubmed: 35063006 pmcid: 8783472
Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81–94. https://doi.org/10.1038/nrclinonc.2017.166 .
doi: 10.1038/nrclinonc.2017.166 pubmed: 29115304
Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, et al. Medulloblastoma. Nat Rev Dis Prim. 2019;5(1):1–20. https://doi.org/10.1038/s41572-019-0063-6 .
doi: 10.1038/s41572-019-0063-6
Turashvili G, Brogi E. Tumor Heterogeneity in Breast Cancer. Front Med. 2017;4. https://www.frontiersin.org/articles/10.3389/fmed.2017.00227 .
Gershanov S, Madiwale S, Feinberg-Gorenshtein G, Vainer I, Nehushtan T, Michowiz S, et al. Classifying Medulloblastoma Subgroups Based on Small, Clinically Achievable Gene Sets. Front Oncol. 2021;11:637482. https://doi.org/10.3389/fonc.2021.637482 .
doi: 10.3389/fonc.2021.637482 pubmed: 34178626 pmcid: 8223061
Northcott PA, Shih DJH, Remke M, Cho YJ, Kool M, Hawkins C, et al. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol. 2012;123(4):615–26. https://doi.org/10.1007/s00401-011-0899-7 .
doi: 10.1007/s00401-011-0899-7 pubmed: 22057785
Wang X, Park J, Susztak K, Zhang NR, Li M. Bulk tissue cell type deconvolution with multi-subject single-cell expression reference. Nat Commun. 2019;10(1):380. https://doi.org/10.1038/s41467-018-08023-x .
doi: 10.1038/s41467-018-08023-x pubmed: 30670690 pmcid: 6342984
Teschendorff AE, Breeze CE, Zheng SC, Beck S. A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies. BMC Bioinformatics. 2017;18(1):105. https://doi.org/10.1186/s12859-017-1511-5 .
doi: 10.1186/s12859-017-1511-5 pubmed: 28193155 pmcid: 5307731
Li H, Sharma A, Ming W, Sun X, Liu H. A deconvolution method and its application in analyzing the cellular fractions in acute myeloid leukemia samples. BMC Genomics. 2020;21(1):652. https://doi.org/10.1186/s12864-020-06888-1 .
doi: 10.1186/s12864-020-06888-1 pubmed: 32967610 pmcid: 7510109
Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7. https://doi.org/10.1038/nmeth.3337 .
doi: 10.1038/nmeth.3337 pubmed: 25822800 pmcid: 4739640
Mullen KM, van Stokkum IHM. nnls: The Lawson-Hanson algorithm for non-negative least squares (NNLS). 2012. R package version 1.4. https://CRAN.R-project.org/package=nnls . Accessed Apr 2022.
Li Z, Wu H. TOAST: improving reference-free cell composition estimation by cross-cell type differential analysis. Genome Biol. 2019;20(1):190. https://doi.org/10.1186/s13059-019-1778-0 .
doi: 10.1186/s13059-019-1778-0 pubmed: 31484546 pmcid: 6727351
Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics. 2013;14(1):7. https://doi.org/10.1186/1471-2105-14-7 .
doi: 10.1186/1471-2105-14-7 pubmed: 23323831 pmcid: 3618321
Huang P, Cai M, Lu X, McKennan C, Wang J. Accurate estimation of rare cell type fractions from tissue omics data via hierarchical deconvolution. Ann Appl Stat. 2024;18(2):1178-94. https://doi.org/10.1214/23-AOAS1829 .
Garmire LX, Li Y, Huang Q, Xu C, Teichmann SA, Kaminski N, et al. Challenges and perspectives in computational deconvolution of genomics data. Nat Methods. 2024;21(3):391–400. https://doi.org/10.1038/s41592-023-02166-6 .
doi: 10.1038/s41592-023-02166-6 pubmed: 38374264
Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773–82. https://doi.org/10.1038/s41587-019-0114-2 .
doi: 10.1038/s41587-019-0114-2 pubmed: 31061481 pmcid: 6610714
Aliee H, Theis FJ. AutoGeneS: Automatic gene selection using multi-objective optimization for RNA-seq deconvolution. Cell Syst. 2021;12(7):706-715.e4. https://doi.org/10.1016/j.cels.2021.05.006 .
doi: 10.1016/j.cels.2021.05.006 pubmed: 34293324
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https://doi.org/10.1093/nar/gkv007 .
doi: 10.1093/nar/gkv007 pubmed: 25605792 pmcid: 4402510
Hao Y, Yan M, Heath BR, Lei YL, Xie Y. Fast and robust deconvolution of tumor infiltrating lymphocyte from expression profiles using least trimmed squares. PLoS Comput Biol. 2019;15(5):e1006976. https://doi.org/10.1371/journal.pcbi.1006976 .
doi: 10.1371/journal.pcbi.1006976 pubmed: 31059559 pmcid: 6522071
Aran D. Cell-Type Enrichment Analysis of Bulk Transcriptomes Using xCell. Methods Mol Biol. 2020;2120:263-276. https://doi.org/10.1007/978-1-0716-0327-7_19 .
Chu T, Wang Z, Pe’er D, Danko CG. BayesPrism Extended Data Figure 9: Comparison between tumor purity inferred by BayesPrism, CIBERSORTx, ABSOLUTE, ESTIMATE and IHC. 2022. (Extended Data Figure 9). https://doi.org/10.1038/s43018-022-00356-3 . Accessed Sept 2023.
Hippen AA, Omran DK, Weber LM, Jung E, Drapkin R, Doherty JA, et al. Performance of computational algorithms to deconvolve heterogeneous bulk ovarian tumor tissue depends on experimental factors. Genome Biol. 2023;24(1):239. https://doi.org/10.1186/s13059-023-03077-7 .
doi: 10.1186/s13059-023-03077-7 pubmed: 37864274 pmcid: 10588129
Chu T, Wang Z, Pe’er D, Danko CG. BayesPrism Source code. 2022. https://github.com/Danko-Lab/BayesPrism/blob/36e6d26f50d402876ee4e64c35e181465b58dda7/BayesPrism/R/run_gibbs.R#L57-L59 . Accessed Mar 2023.
Meng G, Tang W, Huang E, Li Z, Feng H. A comprehensive assessment of cell type-specific differential expression methods in bulk data. Brief Bioinforma. 2023;24(1):bbac516. https://doi.org/10.1093/bib/bbac516 .
doi: 10.1093/bib/bbac516
Jew B, Alvarez M, Rahmani E, Miao Z, Ko A, Garske KM, et al. Accurate estimation of cell composition in bulk expression through robust integration of single-cell information. Nat Commun. 2020;11(1):1971. https://doi.org/10.1038/s41467-020-15816-6 .
doi: 10.1038/s41467-020-15816-6 pubmed: 32332754 pmcid: 7181686
Schelker M, Feau S, Du J, Ranu N, Klipp E, MacBeath G, et al. Estimation of immune cell content in tumour tissue using single-cell RNA-seq data. Nat Commun. 2017;8(1):2032. https://doi.org/10.1038/s41467-017-02289-3 .
doi: 10.1038/s41467-017-02289-3 pubmed: 29230012 pmcid: 5725570
Sturm G, Finotello F, Petitprez F, Zhang JD, Baumbach J, Fridman WH, et al. Single cell dataset curated by Schelker et al. and Sturm et al.; 2018. Github Repository. https://github.com/icbi-lab/immune_deconvolution_benchmark . Accessed Apr 2022.
Riemondy KA, Venkataraman S, Willard N, Nellan A, Sanford B, Griesinger AM, et al. Interactive Visualization of singlg-cell medulloblastoma data using UCSC CellBrowser. 2021. https://d33sxa6bpqwi51.cloudfront.net . Accessed Aug 2022.
Murphy AE, Skene NG. A balanced measure shows superior performance of pseudobulk methods in single-cell RNA-sequencing analysis. Nat Commun. 2022;13(1):7851. https://doi.org/10.1038/s41467-022-35519-4 .
doi: 10.1038/s41467-022-35519-4 pubmed: 36550119 pmcid: 9780232
Squair JW, Gautier M, Kathe C, Anderson MA, James ND, Hutson TH, et al. Confronting false discoveries in single-cell differential expression. Nat Commun. 2021;12(1):5692. https://doi.org/10.1038/s41467-021-25960-2 .
doi: 10.1038/s41467-021-25960-2 pubmed: 34584091 pmcid: 8479118
Lun ATL, McCarthy DJ, Marioni JC. A step-by-step workflow for low-level analysis of single-cell rna-seq data with bioconductor. F1000Res. 2016;5:2122.  https://doi.org/10.12688/f1000research.9501.2 .
Gu Z. Complex heatmap visualization. iMeta. 2022;1(3):e43. https://doi.org/10.1002/imt2.43 .
doi: 10.1002/imt2.43 pubmed: 38868715 pmcid: 10989952
Gu Z, Gu L, Eils R, Schlesner M, Brors B. circlize Implements and enhances circular visualization in R. Bioinformatics (Oxford, England). 2014;30(19):2811–2. https://doi.org/10.1093/bioinformatics/btu393 .
doi: 10.1093/bioinformatics/btu393 pubmed: 24930139
Hu M, Chikina M. Source code and materials in deconvolution benchmarking study. 2024. Zenodo. https://doi.org/10.5281/zenodo.8206516 .
Hu M, Chikina M. deconvBenchmarking R package. 2024. Github. https://github.com/humengying0907/deconvBenchmarking . Accessed Aug 2023.
The Cancer Genome Atlas Research Network. GDC TCGA Melanoma (SKCM) cohort. Xena browswer. https://xenabrowser.net/datapages/ . Accessed May 2023.
The Cancer Genome Atlas Research Network. GDC TCGA Head and Neck Cancer (HNSC) cohort. Xena browswer. https://xenabrowser.net/datapages/ . Accessed May 2023.
Broad Institute of MIT and Harvard. Molecular Signatures Database (MSigDB). https://www.gsea-msigdb.org/gsea/msigdb/ . Accessed Aug 2022.

Auteurs

Mengying Hu (M)

Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, USA.
Joint Carnegie Mellon - University of Pittsburgh Computational Biology PhD Program, University of Pittsburgh, Pittsburgh, USA.

Maria Chikina (M)

Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, USA. mchikina@pitt.edu.
Joint Carnegie Mellon - University of Pittsburgh Computational Biology PhD Program, University of Pittsburgh, Pittsburgh, USA. mchikina@pitt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH